These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2719021)

  • 1. Transient hepatitis due to low dose neuroleptic medication.
    Bui HD; Chaney RH
    Am J Gastroenterol; 1989 May; 84(5):578-9. PubMed ID: 2719021
    [No Abstract]   [Full Text] [Related]  

  • 2. An atypical presentation of neuroleptic malignant syndrome: diagnostic dilemma in a critical care setting.
    Paul M; Michael SG; John S; Lenox RJ
    Respir Care; 2012 Feb; 57(2):315-7. PubMed ID: 21762565
    [No Abstract]   [Full Text] [Related]  

  • 3. [Possible malignant neuroleptic syndrome associated with aripiprazole and imipramine and treated with bromocriptine].
    Lopez E; Fraile S; Hidalgo FJ; García B
    Med Clin (Barc); 2013 Sep; 141(6):273-4. PubMed ID: 23578844
    [No Abstract]   [Full Text] [Related]  

  • 4. Neuroleptic malignant syndrome after imipramine withdrawal.
    Merriam AE
    J Clin Psychopharmacol; 1987 Feb; 7(1):53-4. PubMed ID: 3818994
    [No Abstract]   [Full Text] [Related]  

  • 5. Serotonin syndrome overlapping with neuroleptic malignant syndrome: A case report and approaches for differentially diagnosing the two syndromes.
    Nisijima K
    Asian J Psychiatr; 2015 Dec; 18():100-1. PubMed ID: 26506919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxic hepatitis and single daily dosage imipramine therapy.
    Moskovitz R; DeVane CL; Harris R; Stewart RB
    J Clin Psychiatry; 1982 Apr; 43(4):165-6. PubMed ID: 7068550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The neuroleptic malignant syndrome in an adolescent. Its treatment with dantrolene, bromocryptin and diazepam].
    Real Rodríguez B; Ruibal JL; Grande Rodríguez S; Sueiro Pita B
    An Esp Pediatr; 1996 Jan; 44(1):60-2. PubMed ID: 8849063
    [No Abstract]   [Full Text] [Related]  

  • 8. Tricyclic antidepressant overdose presenting as neuroleptic malignant syndrome.
    Khandelwal V; Gupta N; Agarwal A; Goyal RK
    J Assoc Physicians India; 2002 Apr; 50():614. PubMed ID: 12164430
    [No Abstract]   [Full Text] [Related]  

  • 9. Hypersensitivity myocarditis and hepatitis associated with imipramine and its metabolite, desipramine.
    Morrow PL; Hardin NJ; Bonadies J
    J Forensic Sci; 1989 Jul; 34(4):1016-20. PubMed ID: 2760582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case of nonneuroleptic malignant syndrome.
    Cohen S; Fligner CL; Raisys VA; Luthi R; Dunner DL
    J Clin Psychiatry; 1987 Jul; 48(7):287-8. PubMed ID: 2885311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Exposure to imipramine and toluene in the pharmaceutical industry. Risk of toxic interaction in the liver].
    Trevisan A; Caroldi S; Rosa A; Chiesura P
    Med Lav; 1979; 70(2):105-8. PubMed ID: 470811
    [No Abstract]   [Full Text] [Related]  

  • 12. [Neuroleptic malignant syndrome: 3 clinical cases].
    Retamal P; Vergara N; Báez M
    Rev Med Chil; 1988 Mar; 116(3):264-7. PubMed ID: 3244936
    [No Abstract]   [Full Text] [Related]  

  • 13. [Neuroleptic malignant syndrome in users of risperidone].
    Bonte-Mineur F; Geerlings CJ; Rietveld AP
    Ned Tijdschr Geneeskd; 2005 Jan; 149(3):158-9; author reply 159. PubMed ID: 15693595
    [No Abstract]   [Full Text] [Related]  

  • 14. Cholestatic jaundice during imipramine therapy.
    Short MH; Burns JM; Harris ME
    JAMA; 1968 Nov; 206(8):1791-2. PubMed ID: 5754834
    [No Abstract]   [Full Text] [Related]  

  • 15. [Lethal catatonia and its differential diagnosis with the neuroleptic malignant syndrome].
    Andreu Giménez L; Robert Gates J; Jover Díaz F; Pagán Acosta G; Merino Sánchez J
    Rev Neurol; 2002 Feb 16-28; 34(4):399-400. PubMed ID: 12022063
    [No Abstract]   [Full Text] [Related]  

  • 16. Neuroleptic malignant syndrome induced by low dose aripiprazole in first episode psychosis.
    Evcimen H; Alici-Evcimen Y; Basil B; Mania I; Mathews M; Gorman JM
    J Psychiatr Pract; 2007 Mar; 13(2):117-9. PubMed ID: 17414689
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical differentiation between lethal catatonia and neuroleptic malignant syndrome: a case report].
    Terlikowska M; Marzański M
    Psychiatr Pol; 1995; 29(3):343-8. PubMed ID: 7652087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroleptic malignant syndrome and malignant hyperthermia.
    Merry SN; Merry AF
    N Z Med J; 1988 Jun; 101(848):431. PubMed ID: 3393339
    [No Abstract]   [Full Text] [Related]  

  • 19. [Neuroleptic malignant syndrome].
    Koberstein B; Balzer K; Eikmeier G; Hager W; Goebell H
    Dtsch Med Wochenschr; 1989 May; 114(18):718-21. PubMed ID: 2653767
    [No Abstract]   [Full Text] [Related]  

  • 20. Neuroleptic malignant syndrome.
    Bristow MF; Kohen D
    Br J Hosp Med; 1996 Apr 17-30; 55(8):517-20. PubMed ID: 8732227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.